Bulletin

WHO

Countries commit to develop climate-smart health care at COP26 UN climate conference

November 9, 2021

WHO

WHO issues emergency use listing for eighth COVID-19 vaccine

November 4, 2021

WHO

COVID-19 Virtual Press Conference

November 4, 2021

Roche

IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer

November 2, 2021

WHO

Re-opening – additional call for experts to join the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)

November 1, 2021

WHO

New ACT-Accelerator strategy calls for US$23.4 billion international investment to solve inequities in global access to COVID-19 vaccines, tests & treatments

October 29, 2021

WHO

Less than 10% of African countries to hit key COVID-19 vaccination goal

October 29, 2021

WHO

WHO Director-General's opening remarks at the media briefing on COVID-19

October 28, 2021

Press Information Bureau

Dr Bharati Pawar addresses inaugural session WHO SEAR High-Level Meeting for Renewed TB Response

October 26, 2021

WHO

WHO Delivers Essential Health Supplies to Sudan

October 25, 2021

Roche

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

October 25, 2021

Press Information Bureau

Centre rushes multi-disciplinary team to Kanpur, Uttar Pradesh where a case of Zika Virus Disease has been reported

October 25, 2021

Press Information Bureau

India’s comprehensive investment in Medical Education: ₹17,691.08 Cr invested in 157 new approved Medical Colleges since 2014

October 24, 2021

Roche

Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq(R) (atezolizumab)

October 23, 2021

Roche

FDA approves Roche’s Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD)

October 23, 2021

WHO

WHO unveils action plan to address findings of Independent Commission on DRC SEA allegations

October 22, 2021

< 1 … 74 75 76 77 78 79 80 81 82 … 94 >

Bulletin

Countries commit to develop climate-smart health care at COP26 UN climate conference

WHO issues emergency use listing for eighth COVID-19 vaccine

COVID-19 Virtual Press Conference

IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer

Re-opening – additional call for experts to join the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)

New ACT-Accelerator strategy calls for US$23.4 billion international investment to solve inequities in global access to COVID-19 vaccines, tests & treatments

Less than 10% of African countries to hit key COVID-19 vaccination goal

WHO Director-General's opening remarks at the media briefing on COVID-19

Dr Bharati Pawar addresses inaugural session WHO SEAR High-Level Meeting for Renewed TB Response

WHO Delivers Essential Health Supplies to Sudan

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

Centre rushes multi-disciplinary team to Kanpur, Uttar Pradesh where a case of Zika Virus Disease has been reported

India’s comprehensive investment in Medical Education: ₹17,691.08 Cr invested in 157 new approved Medical Colleges since 2014

Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq(R) (atezolizumab)

FDA approves Roche’s Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD)

WHO unveils action plan to address findings of Independent Commission on DRC SEA allegations

Company

Resources